Tender Code: ICB/EPSA6/RDF-R/PH/13/22
Award Status: Full Winners List
Award Date: 11/07/2023
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
Company Name: | Document No: OF/TM/ HO-16 | ||||||||||
የኢትዮጵያ መድሃኒት አቅራቢ አገልግሎት | ||||||||||||
Ethiopian Pharmaceuticals Supply Service | ||||||||||||
Title: | Effective date : 21/01/2022 | |||||||||||
Re-evaluation Official Winner list | Rev. No.: 1 | Page 1 of 1 | ||||||||||
Tender no, ICB/EPSS6/RDF-R/PH/13/22 | ||||||||||||
Item.No. | Description | Unit | quantity | Winner | Currency | Unit FOB price | Payement Term | Port of shipment | Delivery Time | Remark | ||
Supplier | Country | |||||||||||
71 | Lamotrigine – 50mg – Tablet | 10×10 | 2,559 | Scott-Edil Pharmacia Limited | India | USD | 6.6000 | L/C | Mundra, India | 12 weeks from the date of confirmed order | ||
94 | Oral Rehydration Salt – 20.7g for 1 Littre Preparation – Powder | Retendered | ||||||||||
እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | ||||||||||||
Make sure that this is the correct issue before use | OF for Winner list OF/TM/HO-15 0, 21/01/2022 | |||||||||||
Company Name: | Document No: OF/TM/ HO-17 | |||||||||||
የኢትዮጵያ መድሃኒት አቅራቢ አገልግሎት | ||||||||||||
Ethiopian Pharmaceuticals Supply Service | ||||||||||||
Title: | Effective date : 21/01/2022 | |||||||||||
Reasons for Rejection | Rev. No.: 1 | Page 1 of 1 | ||||||||||
Tender no,:ICB/EPSA6/RDF-R/PH/13/22 | ||||||||||||
Item No | Prdoduct Description | Name of competitor suppliers | Status | Reason of unsuccessfulness | Remark | |||||||
71 | Lamotrigine – 50mg – Tablet | Intas Pharmaceuticals Ltd | Unsuccessful | Valid EFDA GMP Certificate /GMP waiver certificate is not submitted | submitted EFDA GMP Certificate /GMP waiver certificate is outdated | |||||||
Scott-Edil Pharmacia Limited | Winner | *** | ||||||||||
Medochemie Ltd. | Unsuccessful | Supplier is not willing to deliver the product at the port where Ethiopian Airlines would reach | ||||||||||
94 | Oral Rehydration Salt – 20.7g for 1 Littre Preparation – Powder | Retendered | ||||||||||
Bidders who are Unsuccessful on Preliminary Evaluation | ||||||||||||
S/N | Name of Bidder | Reason for Unsuccessfulness | Remark | |||||||||
2 | Aculife Healthcare Private Limited | Submitted bank guaranteed bid bond prepared after bid closing date(@Jan 18/2023) | ||||||||||
5 | Aurobindo Pharma Limited | Price validity is < 120 days (90 days) | ||||||||||
8 | Bal Pharma Limited, India | Bid bond validity is < 148 days(106 days) & delivery period is >90 days(90-120) | ||||||||||
17 | Egyptian Int. Pharmaceutical Industries Co. S. A. E (EIPICO) | Submitted bank guaranteed bid bond prepared after bid closing date(@Jan 16/2023) | ||||||||||
22 | Gulf Pharmaceutical Industries (JULPHAR) | Bidders Delivery schedule is per lots and its Completion period is >90 days | ||||||||||
32 | Kotra Pharma (M) Sdn Bhd | Price validity is < 120 days (90 days) | ||||||||||
42 | Mohammed Hassen Badreg Co.,Ltd (Sanbe Farma) | Price validity is < 120 days (30 days) | ||||||||||
46 | Oceanic Pharmachem Pvt Ltd | Price validity is < 120 days (90 days) | ||||||||||
69 | Zydus Lifesciences Ltd | Bid bond validity is < 148 (116 days) | ||||||||||
Prepared by Yohannes Dereje…………………….. | Checked by Awoke Delelegn…………………. | |||||||||||
እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reasons for Rejection, OF/TM/HO-17 0, 21/01/2022 | |||||||||||
Make sure that this is the correct issue before use |